| scholarly article | Q13442814 |
| P50 | author | Moshe Arditi | Q16147367 |
| Timothy R Crother | Q59683649 | ||
| David M Underhill | Q37385896 | ||
| P2093 | author name string | Kenichi Shimada | |
| Shuang Chen | |||
| Ellena Peterson | |||
| Rosalinda Sorrentino | |||
| Terence M Doherty | |||
| Anatoly V Slepenkin | |||
| Paul W Dempsey | |||
| Randa Alsabeh | |||
| P2860 | cites work | Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB | Q22010046 |
| RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems | Q24292468 | ||
| Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection | Q24292675 | ||
| Nod1-mediated endothelial cell activation by Chlamydophila pneumoniae | Q24338210 | ||
| Murine Nod1 but not its human orthologue mediates innate immune detection of tracheal cytotoxin | Q24539124 | ||
| Nod1 is an essential signal transducer in intestinal epithelial cells infected with bacteria that avoid recognition by toll-like receptors | Q24629037 | ||
| L,L-diaminopimelate aminotransferase, a trans-kingdom enzyme shared by Chlamydia and plants for synthesis of diaminopimelate/lysine | Q24674785 | ||
| Chlamydia pneumoniaeand atherosclerosis | Q54063686 | ||
| Nod1 Participates in the Innate Immune Response toPseudomonas aeruginosa | Q57245053 | ||
| RICK/RIP2 Mediates Innate Immune Responses Induced through Nod1 and Nod2 but Not TLRs | Q57275903 | ||
| IFN- Enhances Production of Nitric Oxide from Macrophages via a Mechanism That Depends on Nucleotide Oligomerization Domain-2 | Q61905389 | ||
| Defective Phagocytosis and Clearance of Pseudomonas aeruginosa in the Lung Following Bone Marrow Transplantation | Q61942141 | ||
| An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways | Q28139919 | ||
| Human CARD4 protein is a novel CED-4/Apaf-1 cell death family member that activates NF-kappaB | Q28142782 | ||
| Involvement of receptor-interacting protein 2 in innate and adaptive immune responses | Q28207221 | ||
| Chlamydia pneumoniae and atherosclerosis | Q28237111 | ||
| Chlamydia pneumoniae inclusion membrane protein Cpn0585 interacts with multiple Rab GTPases | Q28251473 | ||
| Signalling pathways and molecular interactions of NOD1 and NOD2 | Q28298636 | ||
| Nitric oxide and macrophage function | Q29615327 | ||
| Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan | Q29618544 | ||
| A mouse model of Chlamydia pneumoniae strain TWAR pneumonitis | Q33596734 | ||
| Chlamydial infection in inducible nitric oxide synthase knockout mice | Q33751943 | ||
| Characterization of a neutralizing monoclonal antibody directed at the lipopolysaccharide of Chlamydia pneumoniae. | Q33758389 | ||
| Intracellular survival by Chlamydia | Q34156271 | ||
| Neutrophil granulocytes--Trojan horses for Leishmania major and other intracellular microbes? | Q34202144 | ||
| Mechanisms of pathogenesis: evasion of killing by polymorphonuclear leukocytes | Q34276259 | ||
| Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island | Q34359740 | ||
| IFN-gamma production by antigen-presenting cells: mechanisms emerge. | Q34382913 | ||
| NOD-LRR proteins: role in host-microbial interactions and inflammatory disease | Q34426050 | ||
| In vitro and in vivo functional activity of Chlamydia MurA, a UDP-N-acetylglucosamine enolpyruvyl transferase involved in peptidoglycan synthesis and fosfomycin resistance | Q34514901 | ||
| The role of IFN-gamma in the outcome of chlamydial infection | Q34712661 | ||
| The intracellular life of chlamydiae | Q35030148 | ||
| Chlamydia pneumoniae (TWAR). | Q35367697 | ||
| Role of atypical bacterial infection of the lung in predisposition/protection of asthma. | Q35697038 | ||
| Chlamydia pneumoniae--an infectious risk factor for atherosclerosis? | Q35701591 | ||
| Nod1 acts as an intracellular receptor to stimulate chemokine production and neutrophil recruitment in vivo | Q36227882 | ||
| Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro | Q36275624 | ||
| Building the invisible wall: updating the chlamydial peptidoglycan anomaly | Q36368411 | ||
| Amphiphysin IIm is required for survival of Chlamydia pneumoniae in macrophages | Q36402455 | ||
| Intracellular pattern recognition receptors in the host response | Q36528528 | ||
| The cytosolic pattern recognition receptor NOD1 induces inflammatory interleukin-8 during Chlamydia trachomatis infection | Q36747056 | ||
| Muramic acid is not detectable in Chlamydia psittaci or Chlamydia trachomatis by gas chromatography-mass spectrometry. | Q36978668 | ||
| Functional and biochemical analysis of Chlamydia trachomatis MurC, an enzyme displaying UDP-N-acetylmuramate:amino acid ligase activity | Q37051672 | ||
| Interaction of chlamydiae and host cells in vitro | Q37056842 | ||
| Role of toll-like receptors in immune responses to chlamydial infections | Q37108497 | ||
| Chlamydia causes fragmentation of the Golgi compartment to ensure reproduction. | Q37856042 | ||
| Chlamydia pneumoniae-induced foam cell formation requires MyD88-dependent and -independent signaling and is reciprocally modulated by liver X receptor activation | Q37856309 | ||
| Chlamydia pneumoniae--induced macrophage foam cell formation is mediated by Toll-like receptor 2. | Q37860795 | ||
| Stimulation of the cytosolic receptor for peptidoglycan, Nod1, by infection with Chlamydia trachomatis or Chlamydia muridarum. | Q37862344 | ||
| Differential involvement of TLR2 and TLR4 in host survival during pulmonary infection with Chlamydia pneumoniae | Q37862553 | ||
| MyD88 is pivotal for the early inflammatory response and subsequent bacterial clearance and survival in a mouse model of Chlamydia pneumoniae pneumonia | Q37864592 | ||
| Polymorphonuclear neutrophils improve replication of Chlamydia pneumoniae in vivo upon MyD88-dependent attraction | Q37865116 | ||
| Heat shock protein 60 from Chlamydia pneumoniae elicits an unusual set of inflammatory responses via Toll-like receptor 2 and 4 in vivo | Q37866477 | ||
| Intracellular bacterial infection-induced IFN-gamma is critically but not solely dependent on Toll-like receptor 4-myeloid differentiation factor 88-IFN-alpha beta-STAT1 signaling | Q37867184 | ||
| Macrophages, CD4+ or CD8+ cells are each sufficient for protection against Chlamydia pneumoniae infection through their ability to secrete IFN-gamma | Q37867764 | ||
| Chlamydia pneumoniae survival in macrophages is regulated by free Ca2+ dependent reactive nitrogen and oxygen species | Q37869878 | ||
| Role of chlamydial heat shock protein 60 in the stimulation of innate immune cells by Chlamydia pneumoniae | Q37871262 | ||
| Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway | Q37872780 | ||
| IFN-alpha beta-dependent, IFN-gamma secretion by bone marrow-derived macrophages controls an intracellular bacterial infection | Q37873063 | ||
| Regulation and role of IFN-gamma in the innate resistance to infection with Chlamydia pneumoniae | Q37876677 | ||
| Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice. | Q37878887 | ||
| Chlamydia: old ideas crushed, new mysteries bared | Q37879640 | ||
| Antibiotics, peptidoglycan synthesis and genomics: the chlamydial anomaly revisited | Q37879887 | ||
| A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide | Q37879971 | ||
| Type III secretion genes identify a putative virulence locus of Chlamydia | Q37882492 | ||
| Inhibition of intracellular multiplication of human strains of Chlamydia trachomatis by nitric oxide | Q37883224 | ||
| The immunobiology and immunopathology of chlamydial infections | Q37886284 | ||
| Ultrastructural lung pathology of experimental Chlamydia pneumoniae pneumonitis in mice | Q37888544 | ||
| Chlamydia pneumoniae IgG antibody prevalence in south-western and eastern Finland in 1982 and 1987. | Q37889391 | ||
| Gamma interferon-induced nitric oxide production reduces Chlamydia trachomatis infectivity in McCoy cells. | Q37891650 | ||
| Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells | Q40382473 | ||
| Nucleotide-binding oligomerization domain protein 2-deficient mice control infection with Mycobacterium tuberculosis | Q42277166 | ||
| The relation between Chlamydia pneumoniae and atherosclerosis | Q42390881 | ||
| Deoxyribonucleic Acid Relatedness of Chlamydia sp. Strain TWAR to Chlamydia trachomatis and Chlamydia psittaci | Q45311678 | ||
| Receptor-interacting protein-2 deficiency delays macrophage migration and increases intracellular infection during peritoneal dialysis-associated peritonitis | Q46529733 | ||
| NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2. | Q46942398 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Chlamydophila pneumoniae | Q132319 |
| P304 | page(s) | e1000379 | |
| P577 | publication date | 2009-04-10 | |
| P1433 | published in | PLOS Pathogens | Q283209 |
| P1476 | title | The NOD/RIP2 pathway is essential for host defenses against Chlamydophila pneumoniae lung infection | |
| P478 | volume | 5 |
| Q30829026 | A Zebrafish Model for Chlamydia Infection with the Obligate Intracellular Pathogen Waddlia chondrophila |
| Q36651937 | A novel function of MUC18: amplification of lung inflammation during bacterial infection |
| Q61448770 | Activation of Both TLR and NOD Signaling Confers Host Innate Immunity-Mediated Protection Against Microbial Infection |
| Q24293059 | Activation of nucleotide oligomerization domain 2 (NOD2) by human cytomegalovirus initiates innate immune responses and restricts virus replication |
| Q36528505 | Bacterial Muramyl Dipeptide (MDP) Restricts Human Cytomegalovirus Replication via an IFN-β-Dependent Pathway |
| Q41870524 | Btp Proteins from Brucella abortus Modulate the Lung Innate Immune Response to Infection by the Respiratory Route |
| Q33952490 | Caspase-1 dependent IL-1β secretion is critical for host defense in a mouse model of Chlamydia pneumoniae lung infection |
| Q89850495 | Caveolin-mediated endocytosis of the Chlamydia M278 outer membrane peptide encapsulated in poly(lactic acid)-Poly(ethylene glycol) nanoparticles by mouse primary dendritic cells enhances specific immune effectors mediated by MHC class II and CD4+ T |
| Q35035253 | Chlamydia pneumoniae infection in mice induces chronic lung inflammation, iBALT formation, and fibrosis |
| Q33939577 | Chlamydia pneumoniae infection induced allergic airway sensitization is controlled by regulatory T-cells and plasmacytoid dendritic cells |
| Q36786613 | Chlamydial intracellular survival strategies |
| Q37825933 | Chlamydiales and the innate immune response: friend or foe? |
| Q38294397 | Collaborative action of Toll-like and NOD-like receptors as modulators of the inflammatory response to pathogenic bacteria |
| Q24337154 | Control of NOD2 and Rip2-dependent innate immune activation by GEF-H1 |
| Q33877241 | Cooperation between multiple microbial pattern recognition systems is important for host protection against the intracellular pathogen Legionella pneumophila |
| Q35122727 | Current knowledge and future directions of TLR and NOD signaling in sepsis |
| Q37853175 | Deficiency of XIAP leads to sensitization for Chlamydophila pneumoniae pulmonary infection and dysregulation of innate immune response in mice |
| Q40049512 | Dietary l-arginine inhibits intestinal Clostridium perfringens colonisation and attenuates intestinal mucosal injury in broiler chickens |
| Q40403699 | Differential Macrophage Polarization from Pneumocystis in Immunocompetent and Immunosuppressed Hosts: Potential Adjunctive Therapy during Pneumonia |
| Q37997735 | Effector functions of NLRs in the intestine: innate sensing, cell death, and disease |
| Q37231612 | Functions of NOD-Like Receptors in Human Diseases |
| Q37833851 | Hypothetical protein Cpn0423 triggers NOD2 activation and contributes to Chlamydia pneumoniae-mediated inflammation |
| Q36100313 | Impact of micro-environmental changes on respiratory tract infections with intracellular bacteria. |
| Q33901007 | In vitro analysis of acetalated dextran microparticles as a potent delivery platform for vaccine adjuvants |
| Q35754472 | Inducible innate resistance of lung epithelium to infection |
| Q33553163 | Induction of interferon-stimulated genes by Chlamydia pneumoniae in fibroblasts is mediated by intracellular nucleotide-sensing receptors. |
| Q35164422 | Inflammation and fibrosis during Chlamydia pneumoniae infection is regulated by IL-1 and the NLRP3/ASC inflammasome |
| Q30398752 | Inhaled innate immune ligands to prevent pneumonia |
| Q37694915 | Innate immune recognition in infectious and noninfectious diseases of the lung |
| Q27027451 | Innate immune responses to Chlamydia pneumoniae infection: role of TLRs, NLRs, and the inflammasome |
| Q37844340 | Innate immunity in the respiratory epithelium. |
| Q57158084 | Interplay between Peptidoglycan Biology and Virulence in Gram-Negative Pathogens |
| Q28513094 | Intracellular pathogen sensor NOD2 programs macrophages to trigger Notch1 activation |
| Q26863593 | Investigating the role of nucleotide-binding oligomerization domain-like receptors in bacterial lung infection |
| Q35329165 | Mast cells play an important role in chlamydia pneumoniae lung infection by facilitating immune cell recruitment into the airway |
| Q34529521 | Modifications to the peptidoglycan backbone help bacteria to establish infection |
| Q37327180 | MyD88 and Type I interferon receptor-mediated chemokine induction and monocyte recruitment during Listeria monocytogenes infection |
| Q28512466 | MyD88-, but not Nod1- and/or Nod2-deficient mice, show increased susceptibility to polymicrobial sepsis due to impaired local inflammatory response |
| Q37792870 | NF-κB and STAT3 signaling hubs for lung innate immunity |
| Q38169150 | NOD-Like Receptors in Lung Diseases |
| Q38060719 | NOD1 and NOD2 Signaling in Infection and Inflammation. |
| Q34714303 | NOD1 and NOD2 regulation of pulmonary innate immunity to Legionella pneumophila |
| Q37526074 | NOD2 dependent neutrophil recruitment is required for early protective immune responses against infectious Litomosoides sigmodontis L3 larvae |
| Q36156045 | NOD2 signaling contributes to host defense in the lungs against Escherichia coli infection |
| Q37172148 | NOD2, an intracellular innate immune sensor involved in host defense and Crohn's disease |
| Q44461971 | Nod2 deficiency impairs inflammatory and epithelial aspects of the cutaneous wound-healing response |
| Q46242619 | Nod2 is required for the early innate immune clearance of Acinetobacter baumannii from the lungs. |
| Q28079236 | Nod2: A Critical Regulator of Ileal Microbiota and Crohn's Disease |
| Q37845464 | Nucleotide oligomerization domain 1 ligation suppressed murine allergen-specific T-cell proliferation and airway hyperresponsiveness |
| Q47136699 | Nucleotide-Binding Oligomerization Domain 2 Contributes to Limiting Growth of Mycobacterium abscessus in the Lung of Mice by Regulating Cytokines and Nitric Oxide Production |
| Q60924096 | Nucleotide-binding oligomerization domain 1 is dispensable for host immune responses against pulmonary infection of Acinetobacter baumannii in mice |
| Q35246390 | Nucleotide-binding oligomerization domain 2 receptor is expressed in platelets and enhances platelet activation and thrombosis |
| Q34309329 | Nucleotide-oligomerizing domain-1 (NOD1) receptor activation induces pro-inflammatory responses and autophagy in human alveolar macrophages |
| Q27340476 | Plasmacytoid dendritic cells play a role for effective innate immune responses during Chlamydia pneumoniae infection in mice |
| Q37845585 | Progesterone activates multiple innate immune pathways in Chlamydia trachomatis-infected endocervical cells. |
| Q28472320 | Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection |
| Q34924104 | RIP kinases: key decision makers in cell death and innate immunity |
| Q55058146 | RIP2 Is a Critical Regulator for NLRs Signaling and MHC Antigen Presentation but Not for MAPK and PI3K/Akt Pathways. |
| Q34140548 | Rac1 regulates the NLRP3 inflammasome which mediates IL-1beta production in Chlamydophila pneumoniae infected human mononuclear cells |
| Q36488241 | Receptor interacting protein-2 contributes to host defense against Anaplasma phagocytophilum infection |
| Q36474924 | Receptor-Interacting Protein Kinase-2 Inhibition by CYLD Impairs Antibacterial Immune Responses in Macrophages |
| Q35671594 | Receptor-interacting protein 2 controls pulmonary host defense to Escherichia coli infection via the regulation of interleukin-17A. |
| Q34309792 | Role of MyD88 and Toll-like receptors 2 and 4 in the sensing of Parachlamydia acanthamoebae |
| Q39384268 | Role of NOD2 in regulating the immune response to Aspergillus fumigatus |
| Q41807359 | Role of Nod1 in mucosal dendritic cells during Salmonella pathogenicity island 1-independent Salmonella enterica serovar Typhimurium infection |
| Q35870208 | Role of Nucleotide-Binding Oligomerization Domain-Containing (NOD) 2 in Host Defense during Pneumococcal Pneumonia |
| Q26777991 | Role of Nucleotide-binding and Oligomerization Domain 2 Protein (NOD2) in the Development of Atherosclerosis |
| Q26864035 | Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases |
| Q36079175 | Structural characterization of muropeptides from Chlamydia trachomatis peptidoglycan by mass spectrometry resolves "chlamydial anomaly". |
| Q58121724 | T Cell-Intrinsic Receptor Interacting Protein 2 Regulates Pathogenic T Helper 17 Cell Differentiation |
| Q38328275 | The Nod1, Nod2, and Rip2 axis contributes to host immune defense against intracellular Acinetobacter baumannii infection |
| Q83400238 | The RIPK2 gene: a positional candidate for tick burden supported by genetic associations in cattle and immunological response of knockout mouse |
| Q39117827 | The Role of Nucleotide-Binding Oligomerization Domain-Like Receptors in Pulmonary Infection. |
| Q42252766 | The ever-expanding function of NOD2: autophagy, viral recognition, and T cell activation |
| Q37835976 | The role of NOD1 and NOD2 in host defense against chlamydial infection |
| Q30560623 | The role of NOD2 in murine and human melioidosis |
| Q27333845 | The sst1 resistance locus regulates evasion of type I interferon signaling by Chlamydia pneumoniae as a disease tolerance mechanism |
| Q28676201 | Therapeutic targeting of NOD1 receptors |
| Q36617319 | Toll like receptors in diseases of the lung |
| Q40781900 | Transcription Profiling of NOD-like Receptors in the Human Cornea with Disease |
Search more.